A 42-year-old woman is evaluated in the rheumatology clinic for worsening episodes of painful blanching and cyanosis in her fingers upon exposure to cold air. She has a known history of diffuse cutaneous systemic sclerosis and currently takes no medications for her vascular symptoms. Arrange the following therapeutic interventions for secondary Raynaud phenomenon in the correct sequential order of escalation, from initial management to salvage therapy for critical ischemia.
- 1Implement lifestyle modifications, including cold avoidance and smoking cessation.
- 2Initiate monotherapy with an oral dihydropyridine calcium channel blocker.
- 3Add a phosphodiesterase-5 inhibitor for inadequate symptom control.
- 4Administer intravenous prostanoids.
- 5Perform surgical digital sympathectomy.
Answer
The correct escalation sequence is: lifestyle modifications, followed by oral calcium channel blockers, then addition of phosphodiesterase-5 inhibitors, followed by intravenous prostanoids for severe ischemia, and finally surgical digital sympathectomy as salvage therapy.
The management of secondary Raynaud phenomenon follows a strict step-up approach. It begins with essential lifestyle modifications. When pharmacotherapy is needed, a dihydropyridine calcium channel blocker (e.g., nifedipine) is the first-line choice. If monotherapy fails, a phosphodiesterase-5 inhibitor (e.g., sildenafil) is added. For severe manifestations like digital ulcers or critical ischemia, intravenous prostanoids (e.g., iloprost) are indicated. Surgical digital sympathectomy is strictly a salvage therapy for impending tissue necrosis.
Step-by-Step Solution
Key Concept
The stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis progresses from conservative lifestyle measures to oral vasodilators, followed by intravenous therapies, and finally surgical intervention.
Estimated Time:1m 0s